Rocket Pharmaceuticals (RCKT) News Today $8.01 +0.15 (+1.91%) Closing price 05/2/2025 04:00 PM EasternExtended Trading$8.09 +0.08 (+1.00%) As of 05/2/2025 07:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Acuta Capital Partners LLC Decreases Position in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT)Acuta Capital Partners LLC lessened its position in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT - Free Report) by 29.2% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 134,500 shares of the biotechnolMay 4 at 7:13 AM | marketbeat.comBoxer Capital Management LLC Makes New Investment in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT)Boxer Capital Management LLC purchased a new stake in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 1,466,051 shares of the biotechnology coMay 4 at 6:25 AM | marketbeat.comRocket Pharmaceuticals (RCKT) Expected to Announce Earnings on MondayMay 4 at 2:25 AM | americanbankingnews.comPrice T Rowe Associates Inc. MD Sells 59,261 Shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT)Price T Rowe Associates Inc. MD reduced its stake in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT - Free Report) by 1.8% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 3,148,520 shares of the biotechnologyMay 2 at 4:36 AM | marketbeat.comRocket Pharmaceuticals (RCKT) to Release Earnings on MondayRocket Pharmaceuticals (NASDAQ:RCKT) will be releasing its Q1 2025 earnings before the market opens on Monday, May 5. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-5-rocket-pharmaceuticals-inc-stock/)April 30, 2025 | marketbeat.comRenaissance Technologies LLC Acquires Shares of 218,519 Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT)Renaissance Technologies LLC acquired a new stake in shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT - Free Report) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 218,519 shares of the biotechnology company's stockApril 27, 2025 | marketbeat.com48,400 Shares in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Bought by NatixisNatixis acquired a new stake in shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT - Free Report) during the 4th quarter, according to its most recent 13F filing with the SEC. The firm acquired 48,400 shares of the biotechnology company's stock, valued at approximately $608,000. Natixis owned apprApril 26, 2025 | marketbeat.comMarshall Wace LLP Purchases 446,662 Shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT)Marshall Wace LLP raised its holdings in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT - Free Report) by 4,422.4% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 456,762 shares of the biotechnology company's stock after buyinApril 26, 2025 | marketbeat.comRocket Lab USA takes aim at SpaceX with Neutron RocketApril 25, 2025 | msn.comTickets to Rocket Classic, Detroit's PGA Tour stop, now on saleApril 25, 2025 | detroitnews.comWarriors' Steve Kerr shares disappointment in Rocket's fans chants toward Draymond GreenApril 25, 2025 | msn.comWhy Is Rocket Lab Stock Trading Higher On Thursday?April 24, 2025 | benzinga.comRocket Pharmaceuticals (NASDAQ:RCKT) Stock Price Down 3.6% - Time to Sell?Rocket Pharmaceuticals (NASDAQ:RCKT) Shares Down 3.6% - Here's WhyApril 24, 2025 | marketbeat.comRocket Pharmaceuticals (NASDAQ:RCKT) Shares Up 8.9% - Here's What HappenedRocket Pharmaceuticals (NASDAQ:RCKT) Shares Up 8.9% - Time to Buy?April 23, 2025 | marketbeat.comAvoro Capital Advisors LLC Buys New Stake in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT)Avoro Capital Advisors LLC acquired a new stake in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 1,200,000 shares of the biotechnology company's stockApril 23, 2025 | marketbeat.comVoss Capital LP Makes New Investment in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT)Voss Capital LP bought a new stake in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT - Free Report) during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 421,700 shares of the biotechnology company's stock, valued at approximateApril 23, 2025 | marketbeat.comGeode Capital Management LLC Increases Stake in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT)Geode Capital Management LLC grew its holdings in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT - Free Report) by 8.4% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,752,975 shares of the biotechnology compaApril 21, 2025 | marketbeat.comRocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Shares Sold by Alliancebernstein L.P.Alliancebernstein L.P. reduced its holdings in shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT - Free Report) by 74.7% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 73,760 shares of the biotechnologyApril 21, 2025 | marketbeat.comWalleye Capital LLC Has $2.77 Million Holdings in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT)Walleye Capital LLC grew its holdings in shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT - Free Report) by 59.1% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 220,142 shares of the biotecApril 20, 2025 | marketbeat.comJPMorgan Chase & Co. Sells 41,024 Shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT)JPMorgan Chase & Co. reduced its stake in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT - Free Report) by 7.4% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 515,528 shares of the biotechnology company's stock aApril 20, 2025 | marketbeat.comXTX Topco Ltd Has $800,000 Stock Position in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT)XTX Topco Ltd boosted its stake in shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT - Free Report) by 310.5% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 63,634 shares of the biotechnology company's stock aApril 19, 2025 | marketbeat.comOilers' Leon Draisaitl Notches First Career Rocket Richard TrophyApril 18, 2025 | msn.comRocket Pharmaceuticals (NASDAQ:RCKT) Trading Down 7.5% - Here's WhyRocket Pharmaceuticals (NASDAQ:RCKT) Trading Down 7.5% - Here's What HappenedApril 18, 2025 | marketbeat.comRocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Shares Acquired by Synovus Financial CorpSynovus Financial Corp lifted its position in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT - Free Report) by 71.6% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 163,893 shares of the biotechnology company's sApril 18, 2025 | marketbeat.comRocket Pharmaceuticals (NASDAQ:RCKT) Shares Gap Up Following Insider Buying ActivityRocket Pharmaceuticals (NASDAQ:RCKT) Shares Gap Up on Insider Buying ActivityApril 17, 2025 | marketbeat.comInsider Buying: Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) CEO Acquires 20,000 Shares of StockRocket Pharmaceuticals, Inc. (NASDAQ:RCKT - Get Free Report) CEO Gaurav Shah purchased 20,000 shares of Rocket Pharmaceuticals stock in a transaction dated Thursday, April 10th. The shares were acquired at an average cost of $5.08 per share, with a total value of $101,600.00. Following the transaction, the chief executive officer now directly owns 792,680 shares in the company, valued at approximately $4,026,814.40. The trade was a 2.59 % increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link.April 16, 2025 | marketbeat.comRocket Pharmaceuticals (NASDAQ:RCKT) Shares Up 5.5% - What's Next?Rocket Pharmaceuticals (NASDAQ:RCKT) Trading 5.5% Higher - Time to Buy?April 16, 2025 | marketbeat.comRocket Lab Stock Is Ripping Higher Tuesday: Here's WhyApril 15, 2025 | benzinga.comInsider Buying: Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) CEO Purchases 20,000 Shares of StockApril 15, 2025 | insidertrades.comRocket Pharmaceuticals CEO buys $101.6K in common stockApril 15, 2025 | msn.comFranklin Resources Inc. Sells 1,076,785 Shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT)Franklin Resources Inc. lessened its stake in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT - Free Report) by 62.2% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 653,559 shares of the biotechnology company's stock after sellinApril 12, 2025 | marketbeat.comVanguard Group Inc. Purchases 1,040,655 Shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT)Vanguard Group Inc. raised its position in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT - Free Report) by 18.8% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 6,577,595 shares of the biotechnology company's stockApril 12, 2025 | marketbeat.comNeedham & Company LLC Reiterates "Buy" Rating for Rocket Pharmaceuticals (NASDAQ:RCKT)Needham & Company LLC restated a "buy" rating and issued a $42.00 target price on shares of Rocket Pharmaceuticals in a research note on Wednesday.April 11, 2025 | marketbeat.comRocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Insider Buys $99,165.30 in StockApril 11, 2025 | insidertrades.comAaron Ondrey Sells 7,489 Shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) StockRocket Pharmaceuticals, Inc. (NASDAQ:RCKT - Get Free Report) CFO Aaron Ondrey sold 7,489 shares of the stock in a transaction that occurred on Friday, April 4th. The shares were sold at an average price of $5.29, for a total transaction of $39,616.81. Following the transaction, the chief financial officer now owns 129,650 shares in the company, valued at $685,848.50. The trade was a 5.46 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link.April 10, 2025 | marketbeat.comRocket Pharmaceuticals Out Of Orbit, But Ready For RelaunchApril 10, 2025 | seekingalpha.comRocket Pharmaceuticals appoints new Chief OfficerApril 10, 2025 | uk.investing.comRocket Pharmaceuticals (NASDAQ:RCKT) Reaches New 1-Year Low - Here's WhyRocket Pharmaceuticals (NASDAQ:RCKT) Hits New 52-Week Low - Here's What HappenedApril 9, 2025 | marketbeat.comRocket Pharmaceuticals (RCKT): Among Stocks Under $10 that Will TripleApril 9, 2025 | insidermonkey.comADAR1 Capital Management LLC Acquires 207,100 Shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT)ADAR1 Capital Management LLC increased its position in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT - Free Report) by 4,816.3% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 211,400 shares of the biotechnologApril 9, 2025 | marketbeat.comRocket Pharmaceuticals, Inc. (NASDAQ:RCKT) CFO Sells $39,616.81 in StockApril 9, 2025 | insidertrades.comRocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Shares Purchased by ExodusPoint Capital Management LPExodusPoint Capital Management LP boosted its stake in shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT - Free Report) by 189.4% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 189,879 shares of the biotechnology company'April 9, 2025 | marketbeat.comRocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Receives Consensus Rating of "Moderate Buy" from AnalystsShares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT - Get Free Report) have received a consensus rating of "Moderate Buy" from the twelve ratings firms that are currently covering the company, Marketbeat reports. One analyst has rated the stock with a hold recommendation and eleven have given a buApril 9, 2025 | marketbeat.comOvata Capital Management Ltd Buys Shares of 200,000 Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT)Ovata Capital Management Ltd purchased a new position in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 200,000 sharesApril 7, 2025 | marketbeat.comRocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Shares Acquired by Schroder Investment Management GroupSchroder Investment Management Group increased its stake in shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT - Free Report) by 76.0% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 413,550 shares of the biotechnology cApril 7, 2025 | marketbeat.comRocket Pharmaceuticals (NASDAQ:RCKT) Trading 4.5% Higher - Here's What HappenedRocket Pharmaceuticals (NASDAQ:RCKT) Stock Price Up 4.5% - Here's What HappenedApril 4, 2025 | marketbeat.comRocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Shares Purchased by Wellington Management Group LLPWellington Management Group LLP lifted its holdings in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT - Free Report) by 24.5% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 13,995,177 shares of the biotechApril 4, 2025 | marketbeat.comPictet Asset Management Holding SA Sells 68,736 Shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT)Pictet Asset Management Holding SA lessened its stake in shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT - Free Report) by 5.0% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,317,969 shares of theApril 3, 2025 | marketbeat.comRocket Pharmaceuticals (NASDAQ:RCKT) Reaches New 52-Week Low - Here's WhyRocket Pharmaceuticals (NASDAQ:RCKT) Sets New 52-Week Low - Time to Sell?April 2, 2025 | marketbeat.comRocket Pharmaceuticals (NASDAQ:RCKT) Trading Down 15.6% - What's Next?Rocket Pharmaceuticals (NASDAQ:RCKT) Trading Down 15.6% - Time to Sell?April 1, 2025 | marketbeat.com Get Rocket Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for RCKT and its competitors with MarketBeat's FREE daily newsletter. Email Address RCKT Media Mentions By Week RCKT Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RCKT News Sentiment▼0.930.73▲Average Medical News Sentiment RCKT News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RCKT Articles This Week▼56▲RCKT Articles Average Week Get Rocket Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for RCKT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies SRRK News Today VKTX News Today XENE News Today CPRX News Today MOR News Today PTGX News Today HCM News Today IMVT News Today MLTX News Today ACAD News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:RCKT) was last updated on 5/4/2025 by MarketBeat.com Staff From Our PartnersTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredWill May start the next "Great Depression?"You probably haven't heard about this yet... But this could be the biggest wealth building opportunity of t...Behind the Markets | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | SponsoredAll Signs Point To Collapse - 401(k)s/IRAs /Are DoomedRetiring? Not so Fast..Hold Onto Your Bootstraps For A Long Road AheadAmerican Hartford Gold | SponsoredHere’s How to Claim Your Stake in Elon’s Private Company, xAII predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Rocket Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Rocket Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy RCKT Stock Free RCKT Stock Alerts